Biogen Cuts Price for Alzheimer’s Drug Aduhelm by Half

Biogen Cuts Price for Alzheimer’s Drug Aduhelm by Half

This post was originally published on this siteBiogen is slashing the price of its controversial new Alzheimer’s disease treatment Aduhelm in half in a bid to revive a product launch that has stalled in part because of a backlash over the drug’s cost.

Read more
Democrats Reach Deal to Control Drug Prices in Social Policy Bill

Democrats Reach Deal to Control Drug Prices in Social Policy Bill

This post was originally published on this siteThe provision would, for the first time, allow the government to negotiate prices for some medicines covered by Medicare.

Read more